We are not a typical “spray-and-pray” venture capital firm. Our approach is concentrated, high-conviction, and consultative — working side-by-side with our portfolio companies before and after investing.
We typically start working with companies in the Late-Seed and Series A stages. We avoid concept investing and look for marketplace businesses with demonstrated network effects.
We prefer to do consulting work before investing to learn more about companies and demonstrate value to founders. We earn the right to lead deals and sit on boards.
Post-investment, we remain very involved — often serving as a part-time CFO in addition to holding board seats. We aspire to increase ownership throughout the later stages of funding.
Ian is the founder of Nosara Capital and has been an active venture capital investor since 2014, making fifteen investments across ten companies, including LeafLink, Artsy, Cake Technologies, FRND Health, and The Loyalist. Ian has served as Director and part-time CFO at LeafLink, a B2B marketplace for the cannabis industry, since leading the company's $10 million Series A in November 2017. Ian was an early investor in and served on the Advisory Board at Cake Technologies, a mobile payments technology provider for the hospitality industry, until it was acquired by American Express in 2017. Ian also serves as a Director at Braintrust, a TV & Film production company in London.
Prior to founding Nosara Capital, Ian spent five years in the hedge fund industry, most recently as a Partner at New Peak Capital in London, with a focus on digital marketplaces, e-commerce, and online payments. Before moving to London, Ian worked in the technology investment banking group at Bank of America Merrill Lynch in Palo Alto, CA. Ian received a bachelor's degree in systems engineering with minors in mathematics and economics from the University of Pennsylvania and received his MBA from London Business School.
Prior to joining Nosara Capital, Hunter spent four years in the investment banking division at Barclays Capital in New York City. At Barclays, Hunter focused on debt and equity financings, mergers and acquisitions and general corporate finance in the consumer, retail and healthcare industries. Notable transactions in which Hunter was involved include CVS Health's $77 billion acquisition of Aetna, G-III Apparel Group’s $650 million purchase of Donna Karan from LVMH and Canada Goose's $250 million initial public offering. Hunter graduated from Brown University in 2014, where he received a bachelor's degree with a concentration in economics.